These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15243701)

  • 1. T lymphocyte response against pancreatic beta cell antigens in fulminant Type 1 diabetes.
    Kotani R; Nagata M; Imagawa A; Moriyama H; Yasuda H; Miyagawa J; Hanafusa T; Yokono K
    Diabetologia; 2004 Jul; 47(7):1285-1291. PubMed ID: 15243701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group.
    Imagawa A; Hanafusa T; Miyagawa J; Matsuzawa Y
    N Engl J Med; 2000 Feb; 342(5):301-7. PubMed ID: 10655528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amylase alpha-2A autoantibodies: novel marker of autoimmune pancreatitis and fulminant type 1 diabetes.
    Endo T; Takizawa S; Tanaka S; Takahashi M; Fujii H; Kamisawa T; Kobayashi T
    Diabetes; 2009 Mar; 58(3):732-7. PubMed ID: 19001184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of GAD65-reactive T-Cells in type 1 diabetes by immunoglobulin-free ELISPOT assays.
    Kotani R; Nagata M; Moriyama H; Nakayama M; Yamada K; Chowdhury SA; Chakrabarty S; Jin Z; Yasuda H; Yokono K
    Diabetes Care; 2002 Aug; 25(8):1390-7. PubMed ID: 12145240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese.
    Zheng C; Zhou Z; Yang L; Lin J; Huang G; Li X; Zhou W; Wang X; Liu Z
    Diabetes Metab Res Rev; 2011 Jan; 27(1):70-8. PubMed ID: 21218510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes.
    Imagawa A; Hanafusa T; Makino H; Miyagawa JI; Juto P
    Diabetologia; 2005 Feb; 48(2):290-3. PubMed ID: 15654603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological aspects of 'fulminant type 1 diabetes'.
    Nagata M; Moriyama H; Kotani R; Yasuda H; Kishi M; Kurohara M; Hara K; Yokono K
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S99-103. PubMed ID: 17478003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
    Durinovic-Belló I
    Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immune response to diverse islet cell antigens in IDDM.
    Durinovic-Bellò I; Hummel M; Ziegler AG
    Diabetes; 1996 Jun; 45(6):795-800. PubMed ID: 8635655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. A case report.
    Shimada A; Imazu Y; Morinaga S; Funae O; Kasuga A; Atsumi Y; Matsuoka K
    Diabetes Care; 1999 Apr; 22(4):615-7. PubMed ID: 10189541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fulminant Type 1 diabetes in a pregnant woman as an initial manifestation of the insulin autoimmune syndrome.
    Kim HS; Lee TY; Kim EY; Choi JH; Kim SY; Hwang YC; Kang JH; Ahn KJ; Chung HY; Jeong IK
    Diabet Med; 2012 Oct; 29(10):1335-8. PubMed ID: 22356444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 64 kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: co-precipitation with a 38 kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes.
    DeAizpurua HJ; Honeyman MC; Harrison LC
    J Autoimmun; 1992 Dec; 5(6):759-70. PubMed ID: 1489487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-ganglioside autoantibodies in type 1 diabetes.
    Lucchetta M; Rudilosso S; Costa S; Bruttomesso D; Ruggero S; Toffanin E; Faggian D; Plebani M; Battistin L; Alaedini A; Briani C
    Muscle Nerve; 2010 Jan; 41(1):50-3. PubMed ID: 19768773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological abnormalities in islets at diagnosis paralleled further deterioration of glycaemic control in patients with recent-onset Type I (insulin-dependent) diabetes mellitus.
    Imagawa A; Hanafusa T; Itoh N; Waguri M; Yamamoto K; Miyagawa J; Moriwaki M; Yamagata K; Iwahashi H; Sada M; Tsuji T; Tamura S; Kawata S; Kuwajima M; Nakajima H; Namba M; Matsuzawa Y
    Diabetologia; 1999 May; 42(5):574-8. PubMed ID: 10333050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell reactivity to human insulinoma cell line (CM) antigens in patients with type 1 diabetes.
    Monetini L; Cavallo MG; Barone F; Valente L; Russo M; Walker B; Thorpe R; Pozzilli P
    Autoimmunity; 1999; 29(3):171-7. PubMed ID: 10433097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
    Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I
    Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M; Durinovic-Bello I; Ziegler AG
    J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity.
    Imagawa A; Hanafusa T; Tamura S; Moriwaki M; Itoh N; Yamamoto K; Iwahashi H; Yamagata K; Waguri M; Nanmo T; Uno S; Nakajima H; Namba M; Kawata S; Miyagawa JI; Matsuzawa Y
    Diabetes; 2001 Jun; 50(6):1269-73. PubMed ID: 11375326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological Aspects of Fulminant Type 1 Diabetes in Chinese.
    Wang Z; Zheng Y; Tu Y; Dai Z; Lin J; Zhou Z
    J Immunol Res; 2016; 2016():1858202. PubMed ID: 26981545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell response pattern to glutamic acid decarboxylase 65 (GAD65) peptides of newly diagnosed type 1 diabetic patients sharing susceptible HLA haplotypes.
    Rharbaoui F; Mayer A; Granier C; Bouanani M; Thivolet C; Pau B; Orgiazzi J; Madec AM
    Clin Exp Immunol; 1999 Jul; 117(1):30-7. PubMed ID: 10403912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.